These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28660775)

  • 1. The microbiome: current and future view of an ancient paradigm.
    Neish AS; Pacifici R; Mulle JG; Kraft CS; Stephens DS
    Future Microbiol; 2017 Aug; 12():831-834. PubMed ID: 28660775
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic and Modulation of Microbiota: A New Paradigm?
    Rizzatti G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
    Hatton G; Shawcross DL
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):1-2. PubMed ID: 30791837
    [No Abstract]   [Full Text] [Related]  

  • 4. Human microbiome restoration and safety.
    Daliri EB; Tango CN; Lee BH; Oh DH
    Int J Med Microbiol; 2018 Jul; 308(5):487-497. PubMed ID: 29773467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microbiome of the critically ill patient.
    Akrami K; Sweeney DA
    Curr Opin Crit Care; 2018 Feb; 24(1):49-54. PubMed ID: 29257783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
    Cho JA; Chinnapen DJF
    J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the microbiome, probiotics, and 'dysbiosis therapy' in critical illness.
    Wischmeyer PE; McDonald D; Knight R
    Curr Opin Crit Care; 2016 Aug; 22(4):347-53. PubMed ID: 27327243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in autoimmunity: potential for clinical applications.
    Kim D; Yoo SA; Kim WU
    Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The gut microbiota, a new cardiovascular risk factor?].
    Chong-Nguyen C; Duboc H; Sokol H
    Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the gastrointestinal microbiota in small animal health and disease.
    Redfern A; Suchodolski J; Jergens A
    Vet Rec; 2017 Oct; 181(14):370. PubMed ID: 28916525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.
    Shen ZH; Zhu CX; Quan YS; Yang ZY; Wu S; Luo WW; Tan B; Wang XY
    World J Gastroenterol; 2018 Jan; 24(1):5-14. PubMed ID: 29358877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic use during pregnancy: how bad is it?
    Kuperman AA; Koren O
    BMC Med; 2016 Jun; 14(1):91. PubMed ID: 27312712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
    Konturek PC; Zopf Y
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire?
    Biedermann L
    Digestion; 2017; 95(4):327-328. PubMed ID: 28609775
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.